Skip to Content
COVID-19 Resources
Cancer Diagnosis Program (CDP) — Biorepositories & Biospecimen Research Branch (BBRB) Cancer Diagnosis Program (CDP) Biorepositories & Biospecimen Research Branch (BBRB)
Contact NExT
Show menu
Search this site
Last Updated: 07/28/14

Thought Leaders

The National Cancer Institute's (NCI) Office of Biorepositories and Biospecimen Research Branch (BBRB) presents the Thought Leaders of Biospecimen Science video series. These videos feature prominent experts in the field of cancer research and drug development discussing their views on various topics, including the:

  • Latest advances in the field of biospecimen research
  • Challenges of maintaining biospecimen integrity
  • Need for process standardization and common data elements
  • Vision for the future of personalized medicine
David Agus, M.D. David Agus, M.D., explains how biospecimen integrity is impacting patient care. View Videos


Carolyn Compton, M.D., Ph.D., FCAP Carolyn Compton, M.D., Ph.D., FCAP, envisions being able to offer tailor-made treatments to every cancer patient. View Videos


Pierre Hainaut, Ph.D. Pierre Hainaut, Ph.D., discusses the importance of biospecimen integrity and highlights the recent advances made in molecular epidemiology which allow for bridging the gap between causes and disease. View Videos


Elizabeth Hammond, M.D., FCAP Elizabeth Hammond, M.D., FCAP, explains the evolving role of the pathologist in developing tests that actually define treatments, and the role of biospecimen quality in getting accurate results. View Videos


Scott Patterson, Ph.D. Scott Patterson, Ph.D., emphasizes the need for good quality samples for identifying and understanding drug targets, and for the development of targeted therapy. View Videos